0000950170-24-035448.txt : 20240322
0000950170-24-035448.hdr.sgml : 20240322
20240322165535
ACCESSION NUMBER: 0000950170-24-035448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240322
FILED AS OF DATE: 20240322
DATE AS OF CHANGE: 20240322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wills Robert James
CENTRAL INDEX KEY: 0001634189
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 24776003
MAIL ADDRESS:
STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR
CITY: MEMPHIS
STATE: TN
ZIP: 38103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
ownership.xml
4
X0508
4
2024-03-22
true
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001634189
Wills Robert James
C/O CYMABAY THERAPEUTICS, INC.
7601 DUMBARTON CIRCLE
FREMONT
CA
94555
true
false
false
false
false
Common Stock
2024-03-22
4
D
false
30000
D
0
D
Employee Stock Option (right to buy)
5.90
2024-03-22
4
D
false
18000
D
2025-04-15
Common Stock
18000
0
D
Employee Stock Option (right to buy)
2.04
2024-03-22
4
D
false
25000
D
2025-10-05
Common Stock
25000
0
D
Employee Stock Option (right to buy)
1.72
2024-03-22
4
D
false
9000
D
2026-06-27
Common Stock
9000
0
D
Employee Stock Option (right to buy)
3.48
2024-03-22
4
D
false
27000
D
2027-04-26
Common Stock
27000
0
D
Employee Stock Option (right to buy)
5.50
2024-03-22
4
D
false
15000
D
2027-06-27
Common Stock
15000
0
D
Employee Stock Option (right to buy)
7.47
2024-03-22
4
D
false
7500
D
2027-09-21
Common Stock
7500
0
D
Employee Stock Option (right to buy)
11.69
2024-03-22
4
D
false
16000
D
2028-01-23
Common Stock
16000
0
D
Employee Stock Option (right to buy)
8.43
2024-03-22
4
D
false
27705
D
2029-01-28
Common Stock
27705
0
D
Employee Stock Option (right to buy)
4.05
2024-03-22
4
D
false
49245
D
2030-05-14
Common Stock
49245
0
D
Employee Stock Option (right to buy)
5.78
2024-03-22
4
D
false
32000
D
2031-01-25
Common Stock
32000
0
D
Employee Stock Option (right to buy)
2.94
2024-03-22
4
D
false
67000
D
2032-01-24
Common Stock
67000
0
D
Employee Stock Option (right to buy)
7.80
2024-03-22
4
D
false
25000
D
2033-01-24
Common Stock
25000
0
D
Employee Stock Option (right to buy)
22.85
2024-03-22
4
D
false
14010
D
2034-01-23
Common Stock
14010
0
D
Pursuant to the Agreement and Plan of Merger, dated as of February 11, 2024 (the "Merger Agreement"), by and among CymaBay Therapeutics, Inc. ("CymaBay"), Gilead Sciences, Inc., a Delaware corporation ("Gilead"), and Pacific Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Gilead ("Purchaser"), among other things, Purchaser merged with and into the Company (the "Merger"). Accordingly, each outstanding share of CymaBay common stock was converted into the right to receive a cash payment equal to $32.50, less applicable withholding taxes.
Pursuant to the Merger Agreement, each outstanding CymaBay stock option, whether or not vested, was cancelled and converted into the right to receive a cash payment equal to the product of (a) the excess of (i) $32.50 over (ii) the per share exercise price of such stock option, and (b) the total number of shares of CymaBay common stock subject to such stock option immediately prior to the effective time of the Merger, less applicable withholding taxes. Any outstanding CymaBay stock option with an exercise price equal to or greater than $32.50 was canceled for no consideration.
/s/ Paul Quinlan, as attorney-in-fact for Robert Wills
2024-03-22